SEC Form 4 · accession 0000899243-18-003471
CORCEPT THERAPEUTICS INC · CORT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joseph K Belanoff
Officer — Chief Executive Officer · Director
Period of report
Feb 7, 2018
Accepted (ET)
Feb 9, 2018 · 8:15 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001088856
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $16.52 | Feb 7, 2018 | A | 475,000 | A | — | Feb 7, 2028 | Common Stock | 475,000 | 475,000 | D |
Explanation of responses
- F1Shares subject to this stock option vest and become exercisable at the rate of 1/48th of the total number of shares on each monthly anniversary of February 7, 2018, so that the total number of shares subject to this option becomes fully vested and exercisable on February 7, 2022.